<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="0a144591-6cfa-4aed-a067-c95aebc29057"/>
   <code code="34391-3" displayName="HUMAN PRESCRIPTION DRUG LABEL" codeSystem="2.16.840.1.113883.6.1"/>
   <title>5% Dextrose Injection USP</title>
   <effectiveTime value="20240105"/>
   <setId root="60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5"/>
   <versionNumber value="7"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="002397347" root="1.3.6.1.4.1.519.1"/>
            <name>B. Braun Medical Inc.</name>
            <assignedEntity>
               <assignedOrganization/>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="d624a6a9-7a94-4048-afae-2b1dfdaf8dfd"/>
               <code code="48780-1" displayName="SPL listing data elements section" codeSystem="2.16.840.1.113883.6.1"/>
               <effectiveTime value="20221019"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0264-1510" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dextrose</name>
                        <formCode code="C42945" displayName="INJECTION, SOLUTION" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Dextrose</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="50"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="LX22YL083G" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DEXTROSE MONOHYDRATE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5SL0G7R0OK" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ANHYDROUS DEXTROSE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="25"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43186" displayName="CONTAINER" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="116"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0264-1510-36" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43184" displayName="CASE" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19731221"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" displayName="Type 0: Not a Combination Product" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="50"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43186" displayName="CONTAINER" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="84"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0264-1510-31" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43184" displayName="CASE" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19731221"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" displayName="Type 0: Not a Combination Product" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="100"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43186" displayName="CONTAINER" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="64"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0264-1510-32" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43184" displayName="CASE" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19731221"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" displayName="Type 0: Not a Combination Product" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA016730" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" displayName="NDA" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19731221"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" displayName="INTRAVENOUS" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="LINK_e572c12b-689a-4f93-913c-ffc02a3a8399">
               <id root="d1cc83e9-ab07-4ef1-894b-7fd294f86eb2"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Partial Fill</content>
                  </paragraph>
               </text>
               <effectiveTime value="20221019"/>
            </section>
         </component>
         <component>
            <section ID="LINK_b741ef8b-10e6-4512-9983-fcb657b7ede6">
               <id root="d66b82a5-f7dc-4589-a0ba-47640a744bdf"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Each mL of 5% Dextrose Injection USP contains:<br/>
Hydrous Dextrose USP 50 mg; Water for Injection USP qs</paragraph>
                  <paragraph>pH: 4.5 (3.5–6.5)<br/>
Calculated Osmolarity: 250 mOsmol/liter<br/>
Calories per 100 mL: 17</paragraph>
                  <paragraph>This solution is sterile, nonpyrogenic, isotonic and contains no bacteriostatic or antimicrobial agents. This product is intended for intravenous administration.</paragraph>
                  <paragraph>The formula of the active ingredient is:</paragraph>
                  <table>
                     <col/>
                     <col/>
                     <col/>
                     <thead>
                        <tr>
                           <th align="center">Ingredient</th>
                           <th align="center">Molecular Formula</th>
                           <th align="center">Molecular Weight</th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td align="center">  </td>
                           <td align="center"> </td>
                           <td align="center"> </td>
                        </tr>
                        <tr>
                           <td align="center"> Hydrous Dextrose USP</td>
                           <td align="center"> <renderMultiMedia referencedObject="MM1"/>
                           </td>
                           <td align="center"> 198.17<br/>
                              <br/>
                           </td>
                        </tr>
                        <tr>
                           <td align="center">  </td>
                           <td align="center"> </td>
                           <td align="center"> </td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>Not made with natural rubber latex, PVC, or DEHP. </paragraph>
                  <paragraph>The plastic container is a copolymer of ethylene and propylene formulated and developed for parenteral drugs. The copolymer contains no plasticizers and exhibits virtually no leachability. The safety of the plastic container has been confirmed by biological evaluation procedures. The material passes Class VI testing as specified in the U.S. Pharmacopeia for Biological Tests — Plastic Containers. These tests have shown that the container is nontoxic and biologically inert.</paragraph>
                  <paragraph>The container/solution unit is a closed system and is not dependent upon entry of external air during administration. The container has two ports, one is for the intravenous administration set and the other is a medication addition site. Each is covered by a tamperproof barrier. Refer to the <content styleCode="bold">
                        <linkHtml href="#LINK_46f5b477-75e0-4d04-83ae-9815d047c8ff">Directions for Use</linkHtml>
                     </content> of the container to properly identify the ports.</paragraph>
                  <paragraph>No vapor barrier is necessary.</paragraph>
               </text>
               <effectiveTime value="20240105"/>
               <component>
                  <observationMedia ID="MM1">
                     <text>Chemical Structure</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_2cfda638-0af5-4cea-bc6f-ddaa47b96d39">
               <id root="e5f0309b-001e-46e7-ab9d-e2c589e3b3c9"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>5% Dextrose Injection USP provides calories and is a source of water for hydration. It is capable of inducing diuresis depending on the volume administered and the clinical condition of the patient.</paragraph>
                  <paragraph>Dextrose is readily metabolized, may decrease losses of body protein and nitrogen, promotes glycogen deposition and decreases or prevents ketosis if sufficient doses are provided.</paragraph>
                  <paragraph>Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirements range from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).</paragraph>
               </text>
               <effectiveTime value="20221019"/>
            </section>
         </component>
         <component>
            <section ID="LINK_b2d1c2a5-5097-43b7-a156-db93acf17825">
               <id root="dbb138fc-31d3-4c28-8f27-8c3e2ef7b7c9"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>5% Dextrose Injection USP is indicated for use in adults and pediatric patients as sources of calories and water for hydration.</paragraph>
                  <paragraph>This product is designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. Consult prescribing information for <content styleCode="bold">
                        <linkHtml href="#LINK_b2d1c2a5-5097-43b7-a156-db93acf17825">INDICATIONS AND USAGE</linkHtml>
                     </content> of drug additives to be administered in this manner.</paragraph>
               </text>
               <effectiveTime value="20221019"/>
            </section>
         </component>
         <component>
            <section ID="LINK_07167e66-2e8a-4b4d-988e-36568bc5b62c">
               <id root="3ccb2db2-60d1-449a-9fef-37a3eab619de"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>Solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.</paragraph>
                  <paragraph>Do not administer 5% Dextrose Injection USP simultaneously with blood through the same infusion set because hemolysis or pseudoagglutination may occur.</paragraph>
               </text>
               <effectiveTime value="20221019"/>
            </section>
         </component>
         <component>
            <section ID="LINK_f6ca50a3-0131-4342-be96-9a66b1cdfef5">
               <id root="f660a335-78ef-48eb-b2c9-13b50b344086"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <text>
                  <paragraph>The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions.</paragraph>
                  <paragraph>Prolonged infusion of isotonic or hypotonic dextrose in water may increase the volume of extracellular fluid and cause water intoxication.</paragraph>
                  <paragraph>Solutions containing dextrose without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility of agglomeration.</paragraph>
                  <paragraph>Excessive administration of potassium-free dextrose solutions may result in significant hypokalemia. Serum potassium levels should be maintained and potassium supplemented as required.</paragraph>
                  <paragraph>In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum osmolality and possible intracerebral hemorrhage.</paragraph>
               </text>
               <effectiveTime value="20221019"/>
            </section>
         </component>
         <component>
            <section ID="LINK_8cbcb232-2992-47f5-aa05-d1adb55d6267">
               <id root="c8b90c78-1e59-4e65-8b5d-5330e37ede20"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <effectiveTime value="20240105"/>
               <component>
                  <section ID="LINK_e9423b71-ee3a-462c-8470-9d171c95e498">
                     <id root="2d6da5d6-a3fc-4db4-b147-0d3048e48888"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title>
                        <content styleCode="italics">General</content>
                     </title>
                     <text>
                        <paragraph>This solution should be used with care in patients with hypervolemia, renal insufficiency, urinary tract obstruction, or impending or frank cardiac decompensation.</paragraph>
                        <paragraph>Solutions containing dextrose should be used with caution in patients with overt or known subclinical diabetes mellitus or carbohydrate intolerance for any reason.</paragraph>
                        <paragraph>To minimize the risk of possible incompatibilities arising from mixing this solution with other additives that may be prescribed, the final infusate should be inspected for cloudiness or precipitation immediately after mixing, prior to administration, and periodically during administration.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_92c101fa-ca90-4f0d-a15c-c8bfedec2f26">
                     <id root="9a5b49b1-f792-42bb-aa28-12b821c6a1fc"/>
                     <code code="34075-2" codeSystem="2.16.840.1.113883.6.1" displayName="LABORATORY TESTS SECTION"/>
                     <title>
                        <content styleCode="italics">Laboratory Tests</content>
                     </title>
                     <text>
                        <paragraph>Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in this or an alternative solution(s).</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_1ecbde57-7be1-44c4-9608-38209682a19e">
                     <id root="50d11cf8-116c-46ab-afda-240b03023cce"/>
                     <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
                     <title>
                        <content styleCode="italics">Drug Interactions</content>
                     </title>
                     <text>
                        <paragraph>Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_a62bb34c-52b4-411a-b510-4d1eedd7f671">
                     <id root="e461c2ad-26b8-48c2-8f8d-61ff37b98863"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>
                        <content styleCode="italics">Carcinogenesis, Mutagenesis, Impairment of Fertility</content>
                     </title>
                     <text>
                        <paragraph>Studies with 5% Dextrose Injection USP have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_69a48846-e87a-4ed6-9140-006f4a027851">
                     <id root="d54fe323-21ef-4c85-9b45-b4607823e87f"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>
                        <content styleCode="italics">Pregnancy -</content>
                     </title>
                     <effectiveTime value="20240105"/>
                     <component>
                        <section ID="LINK_05cac513-7f05-4fa1-b8b5-189d02bb4c68">
                           <id root="527a5f7b-9e37-4713-a3ac-91993ed37bf1"/>
                           <code code="34077-8" codeSystem="2.16.840.1.113883.6.1" displayName="TERATOGENIC EFFECTS SECTION"/>
                           <title>Teratogenic Effects</title>
                           <text>
                              <paragraph>Animal reproduction studies have not been conducted with 5% Dextrose Injection USP. It is also not known whether 5% Dextrose Injection USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. 5% Dextrose Injection USP should be given to a pregnant woman only if clearly needed.</paragraph>
                           </text>
                           <effectiveTime value="20240105"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="LINK_e7c4807e-031b-486f-ba53-0671749025f9">
                     <id root="11b794cd-a197-417c-94f9-2c17bcae7f6e"/>
                     <code code="34079-4" codeSystem="2.16.840.1.113883.6.1" displayName="LABOR &amp; DELIVERY SECTION"/>
                     <title>
                        <content styleCode="italics">Labor and Delivery</content>
                     </title>
                     <text>
                        <paragraph>As reported in the literature, dextrose solutions have been administered during labor and delivery. Caution should be exercised, and the fluid balance, glucose and electrolyte concentrations and acid-base balance, of both mother and fetus should be evaluated periodically or whenever warranted by the condition of the patient or fetus.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_2ff0f8b6-d235-4a59-9013-bf32316c0b0e">
                     <id root="8f6dbe97-6105-4d10-805d-3bcf59afee7c"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>
                        <content styleCode="italics">Nursing Mothers</content>
                     </title>
                     <text>
                        <paragraph>Because many drugs are excreted in human milk, caution should be exercised when 5% Dextrose Injection USP is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_69553a9b-7cca-4974-a22b-7221826a6ddb">
                     <id root="a62ebe2a-1534-4d8c-a34b-2c14c953c049"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>
                        <content styleCode="italics">Pediatric Use</content>
                     </title>
                     <text>
                        <paragraph>The safety and effectiveness in the pediatric population are based on the similarity of the clinical conditions of the pediatric and adult populations.</paragraph>
                        <paragraph>In neonates or in very small infants even small volumes of fluid may affect fluid and electrolyte balance. Care must be exercised in treatment of neonates, especially pre-term neonates, whose renal function may be immature and whose ability to excrete fluid and solute loads may be limited. Fluid intake, urine output, and serum electrolytes should be monitored closely.</paragraph>
                        <paragraph>In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum osmolality and possible intracerebral hemorrhage.</paragraph>
                        <paragraph>Serum glucose concentrations should be frequently monitored when dextrose is prescribed to pediatric patients, particularly infants, neonates, and low birth weight infants. See <content styleCode="bold">
                              <linkHtml href="#LINK_f6ca50a3-0131-4342-be96-9a66b1cdfef5">WARNINGS</linkHtml>
                           </content> and <content styleCode="bold">
                              <linkHtml href="#LINK_e9760df2-c3eb-44bf-90f6-360763d0e3ef">DOSAGE AND ADMINISTRATION</linkHtml>
                           </content>.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_98c623e6-a3b1-4284-88b9-a1caea96a8cc">
                     <id root="16ed8268-1571-4578-be3b-06c1b3f4eb01"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>
                        <content styleCode="italics">Geriatric Use</content>
                     </title>
                     <text>
                        <paragraph>An evaluation of current literature revealed no clinical experience identifying differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</paragraph>
                        <paragraph>This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_9e9d12d5-a480-4195-84a0-65a87c08094a">
               <id root="9e8dabc9-d2cd-4642-af3b-8c5fbaee1e87"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.</paragraph>
                  <paragraph>The physician should also be alert to the possibility of adverse reactions to drug additives diluted and administered from the plastic partial fill container. Prescribing information for drug additives to be administered in this manner should be consulted.</paragraph>
                  <paragraph>If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.</paragraph>
               </text>
               <effectiveTime value="20221019"/>
            </section>
         </component>
         <component>
            <section ID="LINK_ea99ad69-9272-47d4-a0a2-f5f988b299b4">
               <id root="62af5acd-c3da-4afa-97e2-99c567db574a"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>OVERDOSAGE</title>
               <text>
                  <paragraph>In the event of a fluid or solute overload, reevaluate the patient's condition, and institute appropriate corrective treatment.</paragraph>
                  <paragraph>The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions.</paragraph>
                  <paragraph>Prolonged infusion of isotonic or hypotonic dextrose in water may increase the volume of extracellular fluid and cause water intoxication.</paragraph>
               </text>
               <effectiveTime value="20221019"/>
            </section>
         </component>
         <component>
            <section ID="LINK_e9760df2-c3eb-44bf-90f6-360763d0e3ef">
               <id root="f3811abd-ce0d-48bd-858d-d994fbf6c436"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>This solution is for intravenous use only.</paragraph>
                  <paragraph>As directed by a physician. Dosage is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations.</paragraph>
                  <paragraph>Do not use plastic container in series connection.</paragraph>
                  <paragraph>If administration is controlled by a pumping device, care must be taken to discontinue pumping action before the container runs dry or air embolism may result.</paragraph>
                  <paragraph>This solution is intended for intravenous administration using sterile equipment. It is recommended that intravenous administration apparatus be replaced at least once every 24 hours.</paragraph>
                  <paragraph>Use only if solution is clear and container and seals are intact.</paragraph>
                  <paragraph>When using this product as a diluent or vehicle for administration of drug additives, consult the prescribing information of the drug to be used.</paragraph>
                  <paragraph>Addition of medication should be accomplished using aseptic technique in order to assure sterility.</paragraph>
                  <paragraph>Physicochemical studies have shown that the container and solution can withstand freezing.</paragraph>
                  <paragraph>Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</paragraph>
                  <paragraph>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</paragraph>
               </text>
               <effectiveTime value="20221019"/>
               <component>
                  <section ID="LINK_8e8acda0-1eba-45f1-b16f-2c0355f474b7">
                     <id root="2428662c-565a-40d5-bbfc-bc6b82003d79"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>
                        <content styleCode="italics">Pediatric Use</content>
                     </title>
                     <text>
                        <paragraph>As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.</paragraph>
                        <paragraph>There is no specific pediatric dose. The dose is dependent on weight, clinical condition, and laboratory results. Follow recommendations of appropriate pediatric reference text. See <content styleCode="bold">
                              <linkHtml href="#LINK_f6ca50a3-0131-4342-be96-9a66b1cdfef5">WARNINGS</linkHtml>
                           </content> and <content styleCode="bold">
                              <linkHtml href="#LINK_8cbcb232-2992-47f5-aa05-d1adb55d6267">PRECAUTIONS</linkHtml>
                           </content>.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_c13d6775-f119-4faf-bb51-5b868c1658d5">
               <id root="8bb33fa0-648e-4a43-a195-f18582e87c63"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>5% Dextrose Injection USP is supplied sterile and nonpyrogenic in partial fill polyolefin containers. The 100/150 mL product is packaged 64 per case. The 50/100 mL product is packaged 84 per case. The 25/100 mL product is packaged 116 per case.</paragraph>
                  <table>
                     <col/>
                     <col/>
                     <col/>
                     <thead>
                        <tr>
                           <th align="center">NDC</th>
                           <th>REF</th>
                           <th align="center">Fill/Container (mL)</th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td> 5% Dextrose Injection USP</td>
                           <td> </td>
                           <td align="center"> </td>
                        </tr>
                        <tr>
                           <td align="center"> 0264-1510-36</td>
                           <td> S5104-5410</td>
                           <td align="center"> 25/100</td>
                        </tr>
                        <tr>
                           <td align="center"> 0264-1510-31</td>
                           <td> S5104-5384</td>
                           <td align="center"> 50/100</td>
                        </tr>
                        <tr>
                           <td align="center"> 0264-1510-32</td>
                           <td> S5104-5264</td>
                           <td align="center"> 100/150</td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20221019"/>
               <component>
                  <section ID="LINK_ca4ee73b-8962-4f85-b668-1db65ed5f181">
                     <id root="40cdab8c-8d85-4240-8006-93954cfd8799"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <title/>
                     <text>
                        <paragraph>Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.</paragraph>
                     </text>
                     <effectiveTime value="20221019"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_b8806e8b-a50c-43eb-aba5-5667e01e9b86">
               <id root="16686c97-39de-48ee-b042-c300d63f373d"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>Revised: May 2022</paragraph>
                  <paragraph>PAB is a registered trademark of B. Braun Medical Inc.</paragraph>
               </text>
               <effectiveTime value="20240105"/>
            </section>
         </component>
         <component>
            <section ID="LINK_46f5b477-75e0-4d04-83ae-9815d047c8ff">
               <id root="5d442feb-5e4b-4579-9c52-a14d011be9c3"/>
               <code code="42230-3" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PATIENT PACKAGE INSERT SECTION"/>
               <title>Directions For Use of PAB® Container <br/>Partial Additive Bag</title>
               <text>
                  <paragraph>Aseptic technique is required.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Caution:</content> Before use, perform the following checks: Read the label. Ensure solution is the one ordered and is within the expiration date.</paragraph>
                  <paragraph>Inspect the solution in good light for cloudiness, haze or particulate matter; check the container for leakage or damage. Any container which is suspect should not be used.</paragraph>
                  <paragraph>Use only if solution is clear and container and seals are intact. Single dose container. Discard unused portion. Consult Package Insert for complete product information.</paragraph>
                  <paragraph>The physician should also be alert to the possibility of adverse reactions to drug additives diluted and administered from the plastic partial fill container. Prescribing information for drug additives to be administered in this manner should be consulted.</paragraph>
                  <paragraph>Do not use plastic container in series connection.</paragraph>
                  <paragraph>This solution is intended for intravenous administration using sterile equipment. It is recommended that intravenous administration apparatus be replaced at least once every 24 hours.</paragraph>
                  <paragraph>Physicochemical studies have shown that the container and solution can withstand freezing.</paragraph>
                  <list listType="ordered" styleCode="Arabic">
                     <item>
                        <content styleCode="bold">Identify Two Ports (See Figure A).</content>
                        <br/>
                        <renderMultiMedia referencedObject="MM2"/>
                     </item>
                     <item>
                        <content styleCode="bold">To Add Medication<br/>
                        </content>Remove additive port closure: hold container  below additive port and grasp cap between thumb and forefinger then flip cap upward <content styleCode="bold">(See Figure B). Swab exposed additive port.</content> Using a syringe with 18 gauge or smaller needle, insert cannula through resealable additive port and add desired drug. Mix thoroughly.<br/>Note: Partial fill bags have been designed to accept an overfill of up to 50 mL. <br/>
                        <renderMultiMedia referencedObject="MM3"/>
                     </item>
                     <item>
                        <content styleCode="bold">To Attach Administration Set<br/>
                        </content>To aseptically remove the set port closure: hold container below the set port and grasp the foil tab between the thumb and forefinger then pull the tab in two steps as shown in <content styleCode="bold">Figure C Steps 1 and 2</content>. <br/>
                        <renderMultiMedia referencedObject="MM4"/>
                     </item>
                     <item>Push spike through the diaphragm of the port <content styleCode="bold">(See Figure D)</content>. Hang container using hole on the lower flap. Prime set in accordance with the <content styleCode="bold">Directions for Use</content> provided with the set in use.<br/>
                        <renderMultiMedia referencedObject="MM5"/>
                     </item>
                  </list>
                  <paragraph>When the container is to be used as a diluent and delivery system for intermittent intravenous administration of compatible drug additives, consult prescribing information for <content styleCode="bold">
                        <linkHtml href="#LINK_b2d1c2a5-5097-43b7-a156-db93acf17825">INDICATIONS AND USAGE</linkHtml>
                     </content> of drug additives to be administered in this manner.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Warning:</content> Some additives may be incompatible. Consult with pharmacist. When introducing additives, use aseptic techniques. Mix thoroughly. Do not store.</paragraph>
                  <paragraph>PAB containers can be safely transported in a standard 6-inch carrier through a pneumatic tube system that is well maintained and running properly.</paragraph>
               </text>
               <effectiveTime value="20221019"/>
               <component>
                  <observationMedia ID="MM2">
                     <text>Figure A Illustration</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM3">
                     <text>Figure B Illustration</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM4">
                     <text>Figure C Illustration</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM5">
                     <text>Figure D Illustration</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-5.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_e6cb2c35-4446-4568-bce1-d8a493bbc11d">
               <id root="1da113b8-1942-47f4-b0fa-56e11a0c85bc"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title/>
               <text>
                  <paragraph>
                     <content styleCode="bold">B. Braun Medical Inc.</content>
                     <br/>
Bethlehem, PA 18018-3524 USA<br/>
1-800-227-2862</paragraph>
                  <paragraph>Y36-003-061  LD-213-6</paragraph>
               </text>
               <effectiveTime value="20240105"/>
            </section>
         </component>
         <component>
            <section ID="LINK_ca5b8761-b412-4107-80fc-3749b1a82727">
               <id root="09cbc3f6-8cc4-49ef-b515-6a0dff29fdec"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 100 mL Partial Fill</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">5% Dextrose <br/>
Injection USP</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 0264-1510-32<br/>
REF S5104-5264</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">100 mL Partial Fill<br/>
in 150 mL <br/>
PAB<sup>®</sup> Container </content>
                  </paragraph>
                  <paragraph>Each mL contains:<br/>
Hydrous Dextrose USP 50 mg<br/>
Water for Injection USP qs<br/>
                     <br/>
pH: 4.5 (3.5-6.5)<br/>
Calc. Osmolarity: 250 mOsmol/liter<br/>
                     <br/>
Do not administer simultaneously with blood.<br/>
                     <br/>
Sterile, nonpyrogenic. Single dose container. <br/>
For intravenous use only. Use only if solution is clear <br/>
and container and seals are intact.<br/>
                     <br/>
                     <content styleCode="bold">WARNING:</content> Some additives may be incompatible.<br/>
Consult with pharmacist. When introducing additives, <br/>
use aseptic techniques. Mix thoroughly. Do not store.<br/>
                     <br/>
Recommended Storage: Room temperature (25°C). <br/>
Avoid excessive heat. See Package Insert.         <br/>
                     <br/>
Not made with natural rubber latex, PVC, or DEHP.        Rx only<br/>
                     <br/>
PAB is a registered trademark of B. Braun Medical Inc.</paragraph>
                  <paragraph>
                     <content styleCode="bold">B. Braun Medical Inc.<br/>
                     </content>Bethlehem, PA 18018-3524 USA<br/>
1-800-227-2862</paragraph>
                  <paragraph>Y94-003-465  LD-216-3</paragraph>
                  <paragraph>LOT       EXP</paragraph>
                  <renderMultiMedia referencedObject="MM6"/>
               </text>
               <effectiveTime value="20240105"/>
               <component>
                  <observationMedia ID="MM6">
                     <text>S5104-5264 Container Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-6.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_51529a05-a0af-4782-bccf-c4dd653aa894">
               <id root="16c56393-5f68-4f37-9327-cb6e5b73ed18"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 50 mL Partial Fill</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">5% Dextrose <br/>
Injection USP</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 0264-1510-31<br/>
                        <content styleCode="bold">REF </content>S5104-5384</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">50 mL Partial Fill<br/>
in 100 mL PAB<sup>®</sup> Container</content>
                  </paragraph>
                  <paragraph>Each mL contains: Hydrous Dextrose USP 50 mg; Water for Injection USP qs<br/>
pH: 4.5 (3.5-6.5) Calc. Osmolarity: 250 mOsmol/liter<br/>
                     <br/>
Do not administer simultaneously with blood.<br/>
Sterile, nonpyrogenic. Single dose container. For intravenous use only. <br/>
Use only if solution is clear and container and seals are intact.</paragraph>
                  <paragraph>
                     <content styleCode="bold">WARNING:</content>  Some additives may be incompatible. Consult with<br/>
pharmacist. When introducing additives, use aseptic techniques.<br/>
Mix thoroughly. Do not store.</paragraph>
                  <paragraph>Recommended Storage: Room temperature (25°C). <br/>
Avoid excessive heat. See Package Insert.                 Rx Only<br/>
Not made with natural rubber latex, PVC, or DEHP.</paragraph>
                  <paragraph>PAB is a registered trademark of B. Braun Medical Inc.</paragraph>
                  <paragraph>
                     <content styleCode="bold">B. Braun Medical Inc.<br/>
                     </content>Bethlehem, PA 18018-3524 USA<br/>
1-800-227-2862</paragraph>
                  <paragraph>Y94-003-466   LD-215-3</paragraph>
                  <paragraph>LOT      EXP</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM7"/>
                     <br/>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20240105"/>
               <component>
                  <observationMedia ID="MM7">
                     <text>S5104-5384 Container Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-7.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_2e23f70b-ee5a-46de-b2d5-e5d139d22f64">
               <id root="fddf6aaa-777b-45a5-8b7a-0e5374f72aa2"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 25 mL Partial Fill</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="bold">5% Dextrose<br/>
                        </content>
                     </content>
                     <content styleCode="bold">
                        <content styleCode="bold">Injection USP</content>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 0264-1510-36<br/>
                        <content styleCode="bold">REF </content>S5104-5410</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">25 mL Partial Fill<br/>
in 100 mL PAB<sup>®</sup> Container</content>
                  </paragraph>
                  <paragraph>Each mL contains: Hydrous Dextrose USP 50 mg; Water for Injection USP qs<br/>
pH: 4.5 (3.5-6.5) Calc. Osmolarity: 250 mOsmol/liter</paragraph>
                  <paragraph>Do not administer simultaneously with blood.<br/>
Sterile, nonpyrogenic. Single dose container. For intravenous use only. <br/>
Use only if solution is clear and container and seals are intact.</paragraph>
                  <paragraph>
                     <content styleCode="bold">WARNING:</content>  Some additives may be incompatible. Consult with<br/>
pharmacist. When introducing additives, use aseptic techniques.<br/>
Mix thoroughly. Do not store.</paragraph>
                  <paragraph>Recommended Storage: Room temperature (25°C). <br/>
Avoid excessive heat. See Package Insert.                Rx only<br/>
Not made with natural rubber latex, PVC, or DEHP. </paragraph>
                  <paragraph>PAB is a registered trademark of B. Braun Medical Inc.</paragraph>
                  <paragraph>
                     <content styleCode="bold">B. Braun Medical Inc.<br/>
                     </content>Bethlehem, PA 18018-3524 USA<br/>
1-800-227-2862</paragraph>
                  <paragraph>Y94-003-467   LD-214-3</paragraph>
                  <paragraph>LOT   EXP</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM8"/>
                     <br/>
                     <br/>
                     <br/>
                  </paragraph>
               </text>
               <effectiveTime value="20240105"/>
               <component>
                  <observationMedia ID="MM8">
                     <text>S5104-5410 Container Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dextrose-injection-usp-in-pab-8.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>